Search

Search Constraints

You searched for: Author/Creator Robinson, Bruce

Search Results

2. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Issue 16 (24th April 2015)

3. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment. Issue 6 (11th March 2022)

5. Bayesian approach to determining penetrance of pathogenic SDH variants. Issue 11 (10th September 2018)

6. Blood flow rate: An independent risk factor of mortality in Chinese hemodialysis patients. Issue 3 (22nd September 2021)

7. Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 8 (August 2021)

8. Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience. Issue 5 (25th July 2021)

10. Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours. Issue 3 (13th May 2017)